Considering the adaptive upregulation of programmed cell death ligand 1 (PD-L1) during Dox-based chemotherapy, this platform co-delivered PD-L1 siRNA and Dox into prostate cancer cells. The gene discussed is CD274; the disease is prostate carcinoma.